Abstract:Background Mixed lymphohematopoietic chimerism can provide an effective means of inducing longterm immunological tolerance and has been documented in a monkey allograft model, A conditioning regimen including nonmyeloablative or myeloablative irradiation and splenectomy has been used to induce chimerism in a pig-to-primate transplantation model. Since the presence of anti-Gal alpha 1-3Gal (alpha Gal) natural antibodies leads to the hyperacute rejection of pig organs transplanted into primates, extracorporeal immunoaffinity adsorption (EIA) of anti-alpha Gal antibodies is also included in the regimen. The effect of the tolerance induction protocol on the anti-alpha Gal antibody response has been assessed.Methods. Anti-alpha Gal antibody was measured after the EIA of plasma through an alpha Gal immunoaffinity column in baseline studies involving two unmodified baboons, one splenectomized baboon, and one baboon that received a challenge with porcine bone marrow (BM), and in three groups of baboons (n=2 in each group) that received different conditioning regimens for tolerance induction. Group 1 received a nonmyeloablative conditioning regimen without porcine BM transplantation, Group 2 received nonmyeloablative conditioning with pig BM transplantation and pig cytokine therapy. Group 3 received myeloablative conditioning, an autologous BM transplant (with BM depleted of CD2(+) or CD2(+)/CD20(+) cells), and pig BM transplantation,Results. In the baseline studies, a single EIA of anti-alpha Gal antibodies in an unmodified animal initially depleted anti-alpha Gal antibody, followed by a mild rebound. Nonmyeloablative conditioning (group 1) in the absence of pig cell exposure reduced the rate of anti-alpha Gal antibody return. Pig BM cells markedly stimulated anti-alpha Gal antibody production in an unmodified baboon (alpha Gal IgM and IgG levels increased 40- and 220-fold, respectively). This response was significantly reduced (to an only 2- to 5.5-fold increase of IgM and IgG) in baboons undergoing nonmyeloablative conditioning (group 2). A myeloablative conditioning regimen (group 3) prevented the antibody response to pig BM, with the reduction in response being greater in the baboon that received autologous BM depleted of both CD2(+) and CD20(+) cells. No new antibody directed against pig non-alpha Gal antigens was detected ill any baboon during the 1 month follow-up period.Conclusions. (i) EIA of anti-alpha Gal antibody in unmodified baboons results in a transient depletion followed by a mild rebound of antibody; (ii) exposure to pig BM cells results in a substantial increase in anti-alpha Gal antibody production; (iii) a nonmyeloablative conditioning regimen reduces the rate of antibody return and (iv) markedly reduces the response to pig BM cells; (v) the anti-alpha Gal response is completely suppressed by a myeloablative regimen if CD2(+) and CD20(+) cells are eliminated from the autologous BM inoculum. Furthermore, (vi) challenge with pig BM cells appears to stimulate only an anti-alpha Gal antibody response without the development of other (non-alpha Gal) anti-pig antibodies. We conclude that regimens used for T-cell tolerance induction can be beneficial in reducing the anti-alpha Gal antibody response to porcine BM.

Mixed chimerism induced without lethal conditioning prevents T cell– and anti-Galα1,3Gal–mediated graft rejection

T cell and B cell tolerance to GALalpha1,3GAL-expressing heart xenografts is achieved in alpha1,3-galactosyltransferase-deficient mice by nonmyeloablative induction of mixed chimerism.

Tolerization of Galα1,3Gal‐reactive B Cells in Pre‐sensitized Α1,3‐galactosyltransferase‐deficient Mice by Nonmyeloablative Induction of Mixed Chimerism

Tolerization of Anti-Galalpha1-3gal Natural Antibody-Forming B Cells by Induction of Mixed Chimerism.

T CELL AND B CELL TOLERANCE TO GAL??1,3GAL-EXPRESSING HEART XENOGRAFTS IS ACHIEVED IN ??1,3-GALACTOSYLTRANSFERASE-DEFICIENT MICE BY NONMYELOABLATIVE INDUCTION OF MIXED CHIMERISM1:

Mixed Chimerism Induces Donor-Specific T-cell Tolerance Across a Highly Disparate Xenogeneic Barrier.

Lymphohematopoietic graft-vs.-host reactions can be induced without graft-vs.-host disease in murine mixed chimeras established with a cyclophosphamide-based nonmyeloablative conditioning regimen

Induction of Allogeneic Mixed Chimerism by Immature Dendritic Cells and Bone Marrow Transplantation Leads to Prolonged Tolerance to Major Histocompatibility Complex Disparate Allografts

Simultaneous Blockade of Costimulatory Signals CD28-CD80 and CD40-CD154 Combined with Monoclonal Antibody Against CD25 Induced a Stable Chimerism and Tolerance Without Graft-Versus-host Disease in Rat.

Reduction of Anti-Galα1–3gal Natural Antibodies in Sera of Α1,3-Galactosyltransferase-deficient Mice Receiving Gal-Positive Bone Marrow Transplantation

Galectin-1 is associated with hematopoietic cell engraftment in murine MHC-mismatched allotransplantation

Cardiac Allograft Tolerance Induced by Isogeneic CD4+CD25+ Regulatory T Cells.

Long-term (>1 year) analyses of chimerism and tolerance in mixed allogeneic chimeric mice using normal mouse combinations.

Gal mismatch alone causes skin graft rejection in mice

Double negative Treg cells promote nonmyeloablative bone marrow chimerism by inducing T-cell clonal deletion and suppressing NK cell function.

ANTI-Gal??1-3Gal ANTIBODY RESPONSE TO PORCINE BONE MARROW IN UNMODIFIED BABOONS AND BABOONS CONDITIONED FOR TOLERANCE INDUCTION1

Mesenchymal Stem Cells Enhance the Induction of Mixed Chimerism and Tolerance to Rat Hind-Limb Allografts after Bone Marrow Transplantation

Early allogeneic immune modulation after establishment of donor hematopoietic cell-induced mixed chimerism in a nonhuman primate kidney transplant model

[Xenogeneic Antigens and Immune Response in Pig to Man Xenograft].

Bone Marrow Transplantation Combined with Mesenchymal Stem Cells Induces Immune Tolerance without Cytotoxic Conditioning

Establishment of Nonmyeloablative Bone Marrow Chimerism by Double Negative Treg Cells Through Inducing T Cell Clonal Deletion and Suppressing NK Cell Function (126.1)